Pacemaker lead position may unlock better blood pressure control

NCT ID NCT02909868

Completed Knowledge-focused Sponsor: BackBeat Medical Inc Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether the position of a pacemaker lead in the right ventricle can improve how well the BackBeat Moderato system controls blood pressure. Five people with hypertension who already have a pacemaker will have their heart pressures and volumes measured with the therapy on and off. The goal is to understand which lead location works best, which could lead to more effective blood pressure management.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: BackBeat Moderato pacemaker with Programmable Hypertension Control (PHC) therapy
What this could lead to: If successful, this could help refine pacemaker placement to better control blood pressure in people with hypertension.
What could go wrong: This is a very small sub-study with only 5 participants, so results may not apply to everyone. It is designed to gather data, not to prove a treatment works.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERTENSION

Contacts and locations

Locations

Na Homolce Hospital

Prague, Czechia

More trials for these conditions

Other studies related to the condition(s) this trial covers.